For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
What are the growth projections for the jivi market from 2024 to 2029?
The jivi market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising prevalence of hemophilia, investment in research and development, focus on prophylactic treatments, global healthcare investments, and increasing diagnosis rate.
The jivi market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to a rise in global healthcare expenditure, a rise in the male population, favorable government initiatives, rising awareness and early diagnosis, and increasing focus on personalized medicine. Major trends in the forecast period include rising technological advancements, development of novel hemophilia treatments, popularity of gene therapy, development of novel hemophilia treatments, and shifting focus to extended half life therapies.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20117&type=smp
What strategic initiatives by market players are driving jivi industry growth?
The rising prevalence of hemophilia is expected to propel the growth of the jivi market going forward. Hemophilia is attributed to genetic mutations in the X-linked genes responsible for producing clotting factors, leading to insufficient or defective clotting factors VIII (hemophilia A) or IX (hemophilia B), which impair the blood’s ability to clot effectively. The prevalence of hemophilia is growing due to improved diagnostic capabilities, better awareness, and increased reporting of cases worldwide. Jivi helps hemophilia patients by replacing the deficient Factor VIII with a long-acting recombinant therapy, aiding blood clotting to prevent or control bleeding episodes, while its extended half-life reduces dosing frequency, enhancing patient convenience and adherence. For instance, in November 2022, according to the United Kingdom Hemophilia Centre Doctor’s Organization, a UK-based medical association, the new registrations for Hemophilia A in the United Kingdom in 2021 were 16, which increased to 19 in 2022. Thus, the rising prevalence of hemophilia is driving the growth of the jivi market.
What emerging segments are shaping the future landscape of the jivi industry?
The jivi market covered in this report is segmented –
1) By Formulation: Lyophilized Powder For Reconstitution, Ready-to-use Formulations
2) By Route of Administration: Intravenous, Subcutaneous
3) By Indication: Treatment Of Hemophilia A, Prophylaxis, On-demand Treatment For Bleeding Episodes
4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies
5) By End Use: Hospitals, Hemophilia Treatment Centres, Specialty Clinics, Home Healthcare Settings
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/jivi-global-market-report
#How are key players in the jivi market strengthening their market position?
Major companies operating in the jivi market include Bayer AG
Which geographic areas are contributing significantly to the growth of the jivi sector?
North America was the largest region in the jivi market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the jivi market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Can Companies Use The Jivi Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20117
Need Customized Data On Jivi Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20117&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
